Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Retained Earnings (2016 - 2025)

Nutex Health's Retained Earnings history spans 16 years, with the latest figure at -$286.2 million for Q4 2025.

  • For Q4 2025, Retained Earnings rose 19.83% year-over-year to -$286.2 million; the TTM value through Dec 2025 reached -$286.2 million, up 19.83%, while the annual FY2025 figure was -$286.2 million, 19.83% up from the prior year.
  • Retained Earnings for Q4 2025 was -$286.2 million at Nutex Health, up from -$298.0 million in the prior quarter.
  • Across five years, Retained Earnings topped out at $102.3 million in Q4 2021 and bottomed at -$418.6 million in Q3 2024.
  • The 5-year median for Retained Earnings is -$355.2 million (2024), against an average of -$254.4 million.
  • The largest annual shift saw Retained Earnings surged 661.59% in 2021 before it crashed 1214.62% in 2022.
  • A 5-year view of Retained Earnings shows it stood at $102.3 million in 2021, then tumbled by 455.06% to -$363.3 million in 2022, then decreased by 12.6% to -$409.1 million in 2023, then grew by 12.74% to -$357.0 million in 2024, then increased by 19.83% to -$286.2 million in 2025.
  • Per Business Quant, the three most recent readings for NUTX's Retained Earnings are -$286.2 million (Q4 2025), -$298.0 million (Q3 2025), and -$353.5 million (Q2 2025).